Through empowering and educating patients, funding cutting-edge research, building strategic collaborations and raising public awareness, our goal is to transform lung cancer into a chronically managed disease within 10 years and ultimately to find a cure.

Latest News
Demand A Scan:  Luck Is Not An OptionDemand A Scan: Luck Is Not An Option // There’s a lucky few who get an accidental early cancer detection. As if lucky and cancer belong in the same sentence. But as the story of Evy Schiffman shows, they... Read More READ MORE
Patient-driven ResearchPatient-driven Research // Early detection survivors and patient-driven groups such as the EGFR Resisters, ALK Positive and ROS1ders have joined forces with the Bonnie J. Addario Lung Cancer Foundation (ALCF) to promote research and new treatment options. Much is still unknown about lung cancer... Read More READ MORE
ROS1 Study Open for EnrollmentROS1 Study Open for Enrollment // ALCMI-006 and -007 studies are open and recruiting. Currently, this project is available to patients with the ROS1 mutation in the USA. Dr. Pasi Janne (Harvard) will lead this initiative... Read More READ MORE
Early detection is key to surviving world’s deadliest cancerEarly detection is key to surviving world’s deadliest cancer // Without the CT test that you recommended, I would never have suspected I had lung cancer. I am one of the lucky few cured of lung cancer, a rare outcome for patients diagnosed with the leading cause of cancer deaths annually... Read More READ MORE
The Addario Lung Cancer Foundation Honors Oncologist for Groundbreaking Targeted Therapy Research // Vassiliki A. Papadimitrakopoulou, M.D., honored at the 19th Annual International Lung Cancer Congress. The Bonnie J. Addario Lung Cancer Foundation (ALCF) has selected Vassiliki A. Papadimitrakopoulou, M.D. as the recipient... Read More READ MORE